Automated Immunoassay Analyzers Market
Automated Immunoassay Analyzers Market - Global Industry Assessment & Forecast
#
Pages:
156
2022
Feb - 2022
VMR-1314
Segments Covered
By
Analyzer Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers
-
By
Application Drug Discovery, Genomics, Proteomics, Bioanalysis, Analytical Chemistry, Clinical Diagnostics
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 11.53 Billion |
 Revenue 2030:
|
USD 35.99 Billion |
 Revenue CAGR
(2023 - 2030): |
15.30% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Market Synopsis:
Global Automated Immunoassay Analyzers market is valued at USD 11.53 Billion in 2022 and is projected to attain a value of USD 35.99 Billion by 2030 at a CAGR of 15.30% during the forecast period, 2022–2028. The market for automated immunoassay analyzers is expected to develop due to the growing trend toward lab automation and the rising occurrence of infectious disorders. Due to incremental improvements to current items and expanded clinical applications, these products are gaining appeal. As a result of the increased use of automated immunoassay analyzers, demand and adoption rates will rise, propelling the market forward.
Recent automation and integration trends have resulted in the introduction of unique goods to the industry, hence propelling the market forward. They are increasingly being used for drug discovery by a variety of pharmaceutical and biotechnology companies. To obtain access to hospitals and laboratories, industry competitors are competing on the basis of immunoassay system features, throughput, and menu growth.
Automated Immunoassay Analyzers Market Size, 2022 To 2030 (USD Billion)
AI (GPT) is here !!! Ask questions about Automated Immunoassay Analyzers Market
Increasing Incidence of Chronic and Infectious Diseases
Chronic diseases including diabetes, heart disease, and cancer are on the rise all across the world. Infectious diseases such as SARS-CoV2 (COVID-19), Dengue fever, Hepatitis B, C, HIV, Malaria, Tuberculosis, and others are spreading at an alarming rate. Immunoassay diagnosis has become a critical component of many disorders' diagnosis. Immunoassay technology is improving, resulting in faster results with improved efficacy, detection limits, sensitivity, and cost-effectiveness. The widespread use of fast tests and point-of-care testing for disease diagnosis, as well as drug and alcohol addiction, has propelled the worldwide immunoassay market to new heights.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
Get Access Now
Design Challenges
The technicians face lots of design challenges associated with the immunoassays such as misinterpretation of results. Also, the dearth of skilled professionals in the clinical diagnostics domain have posed challenges from several decades.
The Automated Immunoassay Analyzers market scope can be tabulated as below:
Market Segmentation:
Global Automated Immunoassay Analyzers market is segmented on the basis of Analyzers, into Biochemistry Analyzers, Immuno-based Analyzers, Hematology Analyzers. Based on Application into Drug Discovery, Geonomics, Others. Based on region, the Automated Immunoassay Analyzers market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
North America to Continue Dominating the Automated Immunoassay Analyzers Market
During the projected period, North America is expected to dominate the worldwide Automated Immunoassay Analyzers market, followed by Europe. Increased adoption of technologically advanced Automated Immunoassay Analyzers products, high healthcare expenditures, advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, a large number of Automated Immunoassay Analyzers-based R&D projects, and the presence of a large number of leading Automated Immunoassay Analyzers manufacturers in the region, as well as increased demand for genotyping products from pharmaceutical companies and rising government investments, by government bodies, are responsible for the large share of the North American Automated Immunoassay Analyzers market.
Key Players:
Key participants operating in the Automated Immunoassay Analyzers market is: Abbott Diagnostics (US), Biokit (Spain), Biomerieux (France), Luminex Corporation (US), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany).
The Automated Immunoassay Analyzers market is segmented as follows:
Explore purchase options
Parameter
Details
Segments Covered
By Analyzer
By Application
By Region
Regions & Countries Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs.
FAQ
Frequently Asked Question
What is the global demand for Automated Immunoassay Analyzers in terms of revenue?
-
The global Automated Immunoassay Analyzers valued at USD 11.53 Billion in 2022 and is expected to reach USD 35.99 Billion in 2030 growing at a CAGR of 15.30%.
Which are the prominent players in the market?
-
The prominent players in the market are Abbott Diagnostics (US), Biokit (Spain), Biomerieux (France), Luminex Corporation (US), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany)..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 15.30% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Automated Immunoassay Analyzers include
- Increasing Incidence of Chronic and Infectious Diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Automated Immunoassay Analyzers in 2022.
